Relay Therapeutics (RLAY) Change in Account Payables (2019 - 2024)
Relay Therapeutics (RLAY) posted quarterly Change in Account Payables of -$4.3 million for Q3 2024, down 251.88% year-over-year from $2.8 million in Q4 2023, and down 234.17% quarter-over-quarter from $3.2 million in Q2 2024.
Relay Therapeutics (RLAY) Change in Account Payables (2019 - 2024) Analysis & Trends
Relay Therapeutics (RLAY) has reported Change in Account Payables for 6 consecutive years, with -$4.3 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Change in Account Payables fell 251.88% year-over-year to -$4.3 million; the TTM figure through Sep 2024 stood at -$6.4 million (down 228.7% YoY), while the FY2023 annual figure was -$2.4 million, down 220.36% from the prior year.
- Change in Account Payables fell to -$4.3 million in Q3 2024 per RLAY's latest filing, from $3.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.6 million in Q3 2022 and bottomed at -$5.4 million in Q4 2023.
- Historically, Change in Account Payables has averaged -$46210.5 across 5 years, with a median of -$56000.0 in 2021.
- Annual changes were most pronounced in 2020 — Change in Account Payables jumped 1737.5% — and 2022, when it plunged 5950.0%.
- Relay Therapeutics' Change in Account Payables stood at $1.3 million in 2020, then surged by 89.63% to $2.4 million in 2021, then declined by 19.15% to $2.0 million in 2022, then plunged by 373.21% to -$5.4 million in 2023, then climbed by 19.99% to -$4.3 million in 2024.
- Business Quant data shows RLAY's Change in Account Payables at -$4.3 million in Q3 2024, $3.2 million in Q2 2024, and $102000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -4.30 Mn |
| Sep 30, 2024 | -4.30 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | -5.37 Mn |
| Dec 31, 2023 | -5.37 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | -3.39 Mn |